Shanghai Quanjing Medical Imaging Co., Ltd. (hereinafter referred to as “Universal Medical Imaging” or the “Company”), China’s largest independent diagnostic imaging services company, has completed RMB 600 million in a Series B round of financing. The round was led by Cathay Capital, V Star Capital, and CEC Capital Group’s principal investment arm. Other investors include Taida Group, GT Capital, and existing shareholder Hidea VC.  This is currently the largest investment in the diagnostic imaging services industry in China.

CEC Capital Group served as the exclusive financial advisor of Universal Medical Imaging in this transaction.

Universal Medical Imaging established the first independent diagnostic imaging center in China. The Company focuses on the diagnostic imaging of complex diseases, and provides medical services such as high-resolution diagnostic imaging services, comprehensive health examination services, and multi-disciplinary joint consultation for patients.

Amid the COVID-19 outbreak, the Company has fully leveraged its advantages in accurate diagnostic imaging, offered its cloud-based resource-sharing platform to medical institutes across China, and worked with frontline medical staff to provide diagnostic imaging support.

As an industry leader, Universal Medical Imaging’s network of imaging centers covers key cities across China. The Company will use the proceeds from the financing to continue to build its network and accelerate its expansion in the country.